Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome everyone to the 39th Annual JPMorgan Virtual Health Care Conference. My name is Tess Romero. I'm one of the biotech analysts here at JPMorgan, and the next presenting company that I'm pleased to present is Rigel, and speaking on behalf of the company is CEO, Raul Rodriguez.
And before I turn it over to Raul, I just want to remind everyone that for those on the webcast, if you do have a question, please use the "ask a question" feature in the portal and I would be happy to ask the question on your behalf. Raul, over to you.
Thank you, Tessa, and thank you again to our colleagues at JPMorgan for inviting us to present at their conference. An unusual year, for sure, but it's been a very good year for us, in terms of this conference, and very much appreciate that.
So let me tell you a little bit about Rigel, what we've accomplished, what we look to accomplish in the coming year and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |